aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.
Revenue (Most Recent Fiscal Year) | $0.35M |
Net Income (Most Recent Fiscal Year) | $-50.39M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | -- |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.03 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -14276.77% |
Net Margin (Trailing 12 Months) | -- |
Return on Equity (Trailing 12 Months) | -49.84% |
Return on Assets (Trailing 12 Months) | -39.12% |
Current Ratio (Most Recent Fiscal Quarter) | 6.27 |
Quick Ratio (Most Recent Fiscal Quarter) | 6.27 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.02 |
Inventory Turnover (Trailing 12 Months) | -- |
Book Value per Share (Most Recent Fiscal Quarter) | $1.54 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.25 |
Earnings per Share (Most Recent Fiscal Year) | $-0.94 |
Diluted Earnings per Share (Trailing 12 Months) | $-0.96 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Biotechnology |
Common Shares Outstanding | 67.94M |
Free Float | 65.43M |
Market Capitalization | $108.37M |
Average Volume (Last 20 Days) | 0.32M |
Beta (Past 60 Months) | 1.25 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 3.70% |
Percentage Held By Institutions (Latest 13F Reports) | 61.72% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |